Items where authors include "Nathan, P"

Article

Brown, JE, Royle, K-L orcid.org/0000-0003-0225-1199, Gregory, W et al. (96 more authors) (2023) Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trial. The Lancet Oncology, 24 (3). pp. 213-227. ISSN 1470-2045

Hall, PE, Shepherd, STC, Brown, J et al. (19 more authors) (2020) Radiological Response Heterogeneity Is of Prognostic Significance in Metastatic Renal Cell Carcinoma Treated with Vascular Endothelial Growth Factor-targeted Therapy. European Urology Focus, 6 (5). P999-P1005. ISSN 2405-4569

Gough, H, King, M-F orcid.org/0000-0001-7010-476X, Nathan, P et al. (5 more authors) (2019) Influence of neighbouring structures on building façade pressures: comparison between full-scale, wind-tunnel, CFD and practitioner guidelines. Journal of Wind Engineering and Industrial Aerodynamics, 189. pp. 22-33. ISSN 0167-6105

Collinson, F, Brown, S, Buckley, H orcid.org/0000-0002-9829-5817 et al. (11 more authors) (2018) PRISM: A randomised phase II trial of nivolumab in combination with alternatively scheduled ipilimumab in first-line treatment of patients with advanced or metastatic renal cell carcinoma. Annals of Oncology (Part of special issue:Abstract Book of the 43rd ESMO Congress (ESMO 2018) 19–23 October 2018, Munich, Germany), 29 (8). viii331-viii331. ISSN 0923-7534

Dinnes, J, Saleh, D, Newton-Bishop, J orcid.org/0000-0001-9147-6802 et al. (11 more authors) (2017) Tests to assist in the staging of cutaneous melanoma: a generic protocol. Cochrane Database of Systematic Reviews, 2017 (9). CD012806. ISSN 1465-1858

Powles, T, Brown, J, Larkin, J et al. (17 more authors) (2016) A randomized, double-blind phase II study evaluating cediranib versus cediranib and saracatinib in patients with relapsed metastatic clear-cell renal cancer (COSAK). Annals of Oncology, 27 (5). pp. 880-886. ISSN 0923-7534